P1801

· PharmaEssentia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P1801, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors [Phase 1]